Acne Rosacea Clinical Trial
Official title:
Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study
The pilot study will investigate whether combination treatment of Finacea 15% Gel and Brimonidine 0.33% Gel could be more effective than Brimonidine 0.33% Gel monotherapy in treating both the papules/pustules and erythema associated with rosacea.
Acne rosacea is a chronic inflammatory disease with different components including inflammatory lesions (papules/pustules), erythema and telangiectasia. Brimonidine 0.33% Gel primarily affects the erythematous components of rosacea. As such, combination treatment with a standard rosacea treatment, such as Finacea 15% Gel, may provide additional relief for the inflammatory component of rosacea. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03064438 -
Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea
|
Phase 2 | |
| Active, not recruiting |
NCT05108025 -
DMT310-005 Topical in the Treatment of Acne Rosacea
|
Phase 2 | |
| Completed |
NCT02270411 -
Inflammatory Cells From Various Pathologies
|
||
| Recruiting |
NCT04214483 -
A Pilot Study to Explore the Role of Gut Flora in Acne
|
||
| Completed |
NCT00041977 -
Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
|
Phase 3 | |
| Completed |
NCT03003104 -
DMT210 Topical Gel in the Treatment of Acne Rosacea
|
Phase 2 | |
| Completed |
NCT00580723 -
Effects of PRK 124 Lotion in Acne Rosacea
|
Phase 1/Phase 2 | |
| Completed |
NCT04555525 -
A Pilot Study on the Use of Seysara for Rosacea
|
Phase 4 |